Thermo Fisher Scientific (TMO) Tops Q4 EPS by 3c, Beats on Revenue; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
Tweet
Share
E-mail
Get Alerts TMO Hot Sheet
Price: $682.65 --0%
Financial Fact:
Income from Continuing Operations: 473.5M
Today's EPS Names:
INM, TRI, CRVL, More
Financial Fact:
Income from Continuing Operations: 473.5M
Today's EPS Names:
INM, TRI, CRVL, More
Join SI Premium – FREE
Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $5.67, $0.03 better than the analyst estimate of $5.64. Revenue for the quarter came in at $10.89 billion versus the consensus estimate of $10.73 billion.
Thermo Fisher is initiating a guidance range for full year 2024 with revenue of $42.1 billion to $43.3 billion and adjusted EPS of $20.95 to $22.00.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sotera Health Co. (SHC) Tops Q3 EPS by 2c; Offers Guidance
- Sportradar Group AG (SRAD) Reports In-Line Q3 EPS ; Offers Guidance
- Ardmore Shipping (ASC) Misses Q3 EPS by 30c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
